BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pfizer and BioNTech's Omicron JN.1 COVID-19 Vaccine Receives CHMP Recommendation

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Re...

June 28, 2024 | News

QIAGEN Launches Enhanced QIAstat-Dx Respiratory SARS-CoV-2 Panel in Malaysia

The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia expanded to 23 pathogens, now includes Chlamydophila pneumoniae&nb...

June 04, 2024 | News

ProBioGen and ModeX Therapeutics Partner to Accelerate Development of Multi-Specific COVID-19 Antibody

ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and bioproces...

May 30, 2024 | News

Allucent Secures $25.5 Million Award for Decentralized COVID-19 Trial

Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million...

May 16, 2024 | News

Vaxart Gets $9.27M BARDA Award for Phase 2b COVID-19 Oral Pill Study

“We are very honored to receive this BARDA award, which will support the innovative approach of our oral pill vaccine platform,” said Dr. Micha...

January 22, 2024 | News

Juniper Therapeutics Secures Exclusive SAR Registration Rights for COVID-19 Drug from Ping An-Shionogi HK in Singapore

Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...

December 22, 2023 | News

CDC Provides Update on SARS-CoV-2 Variant JN.1 Surveillance

Understanding JN.1: Key Points Variant Characteristics: The SARS-CoV-2 virus responsible for COVID-19 is subject to constant evolution, leading to...

December 17, 2023 | News

JN.1 Variant Takes Center Stage in Singapore's COVID-19 Resurgence

Surge in Cases and JN.1's Dominance From December 3 to 9, the number of COVID-19 cases in Singapore skyrocketed to 56,043, marking a staggering 7...

December 17, 2023 | News

Decoding JN.1: A Comprehensive Exploration of the Latest Covid-19 Variant

Symptoms of JN.1: Unmasking the Invisible Threat JN.1's clinical presentation mirrors that of Influenza-Like Illness (ILI), with patients commonly experien...

December 17, 2023 | News

Thermo Fisher Unveils Automated Solutions for Respiratory Testing

New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories. ...

December 12, 2023 | News

Novavax's COVID-19 Vaccine Now Available to All 194 WHO Member States

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced that Nuvaxovid™ XBB.1.5 ...

November 29, 2023 | News

China Faces Surge in 'Undiagnosed Pneumonia' Cases Among Children

The outbreak initially surfaced in northern China, prompting the World Health Organization (WHO) to issue an "official request" to ...

November 27, 2023 | News

Novavax's Nuvaxovid™ COVID-19 Vaccine Gains Full Approval in Singapore.

"The full approval of our prototype vaccine will enable us to file for approval of our updated protein-based non-mRNA COVID-19 vaccine in the coming w...

October 19, 2023 | News

Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...

October 04, 2023 | News

Stay Connected